Nandrolone, also known as 19-nortestosterone, is an endogenous androgen. It is also an anabolic steroid which is medically used in the form of esters such as nandrolone decanoate and nandrolone phenylpropionate. Chemically 19-nortestosterone has formula C18H26O2 and a molecular weight of 274.4 g mol, and it acts primarily as an androgen receptor agonist with pronounced anabolic effects relative to androgenic effects. In clinical and pharmaceutical contexts nandrolone esters are administered by intramuscular injection to prolong systemic exposure; decanoate provides a long depot half life measured in days to weeks while phenylpropionate has a substantially shorter duration. Nandrolone undergoes reduction by 5 alpha reductase to form dihydronandrolone metabolites that have different receptor affinities than testosterone metabolites, and it aromatizes to estradiol to a lesser extent than testosterone which partially explains its estrogenic side effect profile. Standard characterization and quality control rely on HPLC U V, GC MS and NMR methods and typical physicochemical identifiers include a melting point for the steroidal core in the mid 160 degrees C range for the free base.
Parent: Nandrolone
Parent: Nandrolone
Parent: Nandrolone
Pharmaceutical specifications for nandrolone active pharmaceutical ingredients and ester preparations normally set stringent limits on related substances and total impurities to ensure safety and consistency. Typical assay acceptance is greater than or equal to 97.0 percent by weight for the labeled steroid ester or free base. Individual related steroids such as 19-norandrostenedione, 19-norandrostenediol and 5 alpha dihydronandrolone are commonly limited to no more than 0.5 percent each, with the sum of specified related compounds often limited to 1.0 percent or less. Unknown or unspecified impurities are generally restricted to trace levels for each impurity, commonly not exceeding 0.1 percent individually and not exceeding 2.0 percent for total impurities. Residual solvents, ester hydrolysis products and free fatty acid residues in ester formulations are controlled by separate limits consistent with pharmacopeial guidelines and are monitored by validated GC or HPLC methods.
Yes, Nandrolone and other androgenic anabolic steroids suppress the hypothalamic pituitary gonadal axis through negative feedback, which reduces luteinizing hormone and follicle stimulating hormone secretion and can markedly decrease spermatogenesis, sperm concentration and motility. The degree and duration of suppression depend on dose and treatment length and recovery of sperm parameters can occur after cessation but may take months and is variable.
Nandrolone can alter mood and behavior in some individuals. Compared with testosterone it has a different behavioral profile and is not uniformly associated with severe aggression, but mood changes, irritability and increased aggression have been reported in susceptible persons and at supraphysiological doses. Individual responses vary and psychiatric history and concurrent factors influence risk.
Nandrolone is not a direct lipolytic drug, but by increasing lean body mass, protein synthesis and potentially basal metabolic rate it can contribute to reductions in fat mass as part of an overall regimen. Changes in body composition are secondary to anabolic effects and require appropriate diet and exercise for meaningful fat loss.
